UniProt ID | INP5K_HUMAN | |
---|---|---|
UniProt AC | Q9BT40 | |
Protein Name | Inositol polyphosphate 5-phosphatase K {ECO:0000305} | |
Gene Name | INPP5K {ECO:0000312|HGNC:HGNC:33882} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 448 | |
Subcellular Localization | Endoplasmic reticulum . Following stimulation with EGF, translocates to membrane ruffles. | |
Protein Description | Inositol 5-phosphatase which acts on inositol 1,4,5-trisphosphate, inositol 1,3,4,5-tetrakisphosphate, phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. Has 6-fold higher affinity for phosphatidylinositol 4,5-bisphosphate than for inositol 1,4,5-trisphosphate. [PubMed: 10753883 Negatively regulates assembly of the actin cytoskeleton. Controls insulin-dependent glucose uptake among inositol 3,4,5-trisphosphate phosphatases; therefore, is the specific regulator for insulin signaling in skeletal muscle (By similarity] | |
Protein Sequence | MSSRKLSGPKGRRLSIHVVTWNVASAAPPLDLSDLLQLNNRNLNLDIYVIGLQELNSGIISLLSDAAFNDSWSSFLMDVLSPLSFIKVSHVRMQGILLLVFAKYQHLPYIQILSTKSTPTGLFGYWGNKGGVNICLKLYGYYVSIINCHLPPHISNNYQRLEHFDRILEMQNCEGRDIPNILDHDLIIWFGDMNFRIEDFGLHFVRESIKNRCYGGLWEKDQLSIAKKHDPLLREFQEGRLLFPPTYKFDRNSNDYDTSEKKRKPAWTDRILWRLKRQPCAGPDTPIPPASHFSLSLRGYSSHMTYGISDHKPVSGTFDLELKPLVSAPLIVLMPEDLWTVENDMMVSYSSTSDFPSSPWDWIGLYKVGLRDVNDYVSYAWVGDSKVSCSDNLNQVYIDISNIPTTEDEFLLCYYSNSLRSVVGISRPFQIPPGSLREDPLGEAQPQI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MSSRKLSGPKGRRL -CCCCCCCCCCCCCE | 56.96 | 29514088 | |
84 | Phosphorylation | MDVLSPLSFIKVSHV HHHHCHHHHCCCCCE | 28.45 | 24719451 | |
114 | Phosphorylation | LPYIQILSTKSTPTG CCEEEEECCCCCCCC | 35.10 | 24719451 | |
172 (in isoform 2) | Ubiquitination | - | 25.21 | 21890473 | |
220 | Ubiquitination | CYGGLWEKDQLSIAK CCCCCCHHHHHHHHH | 38.91 | - | |
228 | Ubiquitination | DQLSIAKKHDPLLRE HHHHHHHHHCHHHHH | 44.19 | - | |
248 | Ubiquitination | LLFPPTYKFDRNSND CCCCCCCCCCCCCCC | 43.18 | 21890473 | |
248 (in isoform 1) | Ubiquitination | - | 43.18 | 21890473 | |
294 | Phosphorylation | IPPASHFSLSLRGYS CCCCHHEEEEECCCC | 16.18 | 17081983 | |
296 | Phosphorylation | PASHFSLSLRGYSSH CCHHEEEEECCCCCC | 18.15 | 17081983 | |
388 | Phosphorylation | WVGDSKVSCSDNLNQ EECCCCEECCCCCCE | 16.19 | 22210691 | |
406 | Phosphorylation | DISNIPTTEDEFLLC ECCCCCCCCCEEEHH | 35.76 | 22210691 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of INP5K_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of INP5K_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of INP5K_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NCOR2_HUMAN | NCOR2 | physical | 11509665 | |
TANK_HUMAN | TANK | physical | 21988832 | |
FATE1_HUMAN | FATE1 | physical | 25416956 | |
MD2BP_HUMAN | MAD2L1BP | physical | 28514442 | |
KTNA1_HUMAN | KATNA1 | physical | 28514442 | |
UBP47_HUMAN | USP47 | physical | 28514442 | |
RFX1_HUMAN | RFX1 | physical | 28514442 | |
UBB_HUMAN | UBB | physical | 28514442 | |
CA131_HUMAN | C1orf131 | physical | 28514442 | |
PESC_HUMAN | PES1 | physical | 28514442 | |
PUR2_HUMAN | GART | physical | 28514442 | |
ABHDA_HUMAN | ABHD10 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...